PR001236 (Project)

Id Namespace:

UCSD Metabolomics Workbench

Identifier Namespace (Entity type)

Dcc Asset:

MW submission packet 20250922.zip

Processed File (Entity type)

Dcc:

Metabolomics

DCC (Entity type)

Persistent Id:http://dx.doi.org/10.21228/M8Z10X

Description:Methotrexate (MTX) efficacy in the treatment of rheumatoid arthritis (RA) is variable and unpredictable, resulting in a need to identify biomarkers to guide drug therapy. This study evaluates changes in the plasma metabolome associated with response to MTX in RA with the goal of understanding the metabolic basis for MTX efficacy towards the identification of potential metabolic biomarkers of MTX response.

Results found

Linked to

	Label	Description
	PPR00001 Project (Entity type)	Metabolomics
	SU002027 Subject (Entity type)	A subject from Metabolomics produced as part of the PR001236 project
	SA183895 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183873 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183900 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183921 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183922 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183898 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183905 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project
	SA183904 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001236 project

PPR00001

Project (Entity type)

Metabolomics

SU002027

Subject (Entity type)

A subject from Metabolomics produced as part of the PR001236 project

SA183895

Biosample (Entity type)